PUBLISHER: The Business Research Company | PRODUCT CODE: 1939341
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939341
A biodegradable hemostat is a medical device designed to assist in blood clotting and control bleeding by triggering or speeding up the body's natural coagulation process. It is made to be safely absorbed and broken down by the body over time, eliminating the need for surgical removal. These hemostats are developed with biocompatibility to reduce the risk of adverse reactions while promoting wound healing.
The main types of biodegradable hemostats include natural polymer-based, synthetic polymer-based, composite, cellulose-based, and gelatin-based hemostats. Natural polymer-based hemostats are derived from naturally sourced polymers that aid in stopping bleeding by supporting blood clot formation during medical procedures. They come in various forms such as powders, granules, liquids, foams, and films or sheets, and are used in surgeries, trauma care, dental procedures, laparoscopic surgeries, and more. These products are distributed through direct sales, distributors, e-commerce platforms, pharmaceutical retailers, and healthcare supply companies, serving end users like hospitals, ambulatory surgical centers, clinics, research labs, and others.
Tariffs are impacting the biodegradable hemostat market by increasing costs for imported raw materials such as natural polymers, synthetic biomaterials, and specialized manufacturing inputs. Product segments like composite and synthetic polymer-based hemostats are most affected, particularly in Asia-Pacific and Europe where cross-border sourcing is common. These cost pressures have influenced pricing and supply chain strategies for manufacturers. However, tariffs have also encouraged local sourcing, domestic production, and innovation in alternative biodegradable materials, supporting long-term market growth.
The biodegradable hemostat market research report is one of a series of new reports from The Business Research Company that provides biodegradable hemostat market statistics, including biodegradable hemostat industry global market size, regional shares, competitors with a biodegradable hemostat market share, detailed biodegradable hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the biodegradable hemostat industry. This biodegradable hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biodegradable hemostat market size has grown rapidly in recent years. It will grow from $0.97 billion in 2025 to $1.08 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to reliance on conventional non-absorbable hemostats, growing surgical procedure volumes, increasing hospital infrastructure, rising awareness of blood loss management, adoption of basic wound care technologies.
The biodegradable hemostat market size is expected to see rapid growth in the next few years. It will grow to $1.63 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to advancements in polymer and biomaterial science, growth in minimally invasive surgical procedures, rising trauma and emergency cases, increasing regulatory approvals for biodegradable devices, expansion of ambulatory surgical centers. Major trends in the forecast period include rising adoption of absorbable hemostatic products, growing preference for biocompatible and bioabsorbable materials, increasing use in minimally invasive and laparoscopic surgeries, expansion of advanced hemostats in trauma and emergency care, higher demand for ready-to-use and easy-to-apply hemostats.
The rising number of surgical procedures is anticipated to drive the expansion of the biodegradable hemostat market in the coming years. Surgical procedures are medical interventions carried out by healthcare professionals using specialized instruments to treat, repair, or remove parts of the body for health-related reasons. The growth in surgical procedures is primarily due to the increasing prevalence of chronic conditions, which often require surgical intervention to manage health problems and enhance patient outcomes. Biodegradable hemostats provide a benefit in surgeries, as they naturally degrade within the body after use, eliminating the need for removal and reducing the risk of post-surgical complications. For example, in January 2025, according to Intuitive Surgical Inc., a US-based medical device company, OUS general surgery procedures rose by approximately 35% in 2024, following a growth of around 42% in 2023. Colorectal procedures contributed the largest share of additional volume in both years. Consequently, the increasing number of surgical procedures is fueling the growth of the biodegradable hemostat market.
Key players in the biodegradable hemostat market are concentrating on developing innovative solutions such as plant-based cellulose matrices to rapidly control bleeding and reduce blood loss. Plant-based cellulose matrices are biodegradable materials derived from plant fibers that provide a natural support structure and are safely absorbed by the body, making them suitable for medical use. In April 2024, LifeScience PLUS, a US-based medical device company, introduced DonorSeal, a distinctive hemostatic dressing made entirely from plant-sourced cellulose. DonorSeal forms a gel upon contact with blood, effectively stopping bleeding while being fully biodegradable, absorbable, non-toxic, and pH neutral, making it safe for patients on blood thinners. It also creates a moist, soothing environment that promotes natural tissue healing. The dressing can be removed easily without reopening wounds or sticking, enhancing comfort and speeding recovery at donor sites.
In March 2023, Medtrade Products Ltd, a UK-based biotechnology firm specializing in haemostasis, wound care, and trauma solutions, collaborated with Laubscher and Co AG to launch the CELOX PPH uterine haemostatic tamponade solution throughout Switzerland to tackle postpartum haemorrhage. Through this partnership, Medtrade aims to broaden access to its advanced haemostat technologies, enhance its presence in the Swiss market, and contribute to better maternal outcomes through rapid and effective bleeding management. Laubscher and Co AG is a Switzerland-based medical device company focusing on surgical and women's health solutions.
Major companies operating in the biodegradable hemostat market are Johnson And Johnson Services Inc, Medtronic Plc, Stryker Corporation, Baxter International Inc, Meril Life Sciences Pvt Ltd, Samyang Holdings Corp, Molnlycke Health Care AB, GELITA Medical GmbH, B Braun Melsungen AG, Tricol Biomedical Inc, Hemostasis LLC, Cura Medical, RevMedx Inc, Speed Care Mineral GmbH, Regenity, C R Bard Inc, Integra LifeSciences Corporation, Advanced Medical Solutions Group plc, Anika Therapeutics Inc, Marine Polymer Technologies Inc, Axio Biosolutions Pvt Ltd, Biom Up Inc
North America was the largest region in the biodegradable hemostat market in 2025. The regions covered in the biodegradable hemostat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the biodegradable hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The biodegradable hemostat market consists of sales of polysaccharide hemostatic powders, flowable hemostatic agents, plant-based absorbable hemostats, and hydrogel-based hemostatic patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biodegradable Hemostat Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses biodegradable hemostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for biodegradable hemostat ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biodegradable hemostat market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.